← العودة إلى الصفحة الرئيسية
الولايات المتحدة · منصات وبيانات · MarketBeat

Milestone Pharmaceuticals (NASDAQ:MIST) Stock Rating Upgraded by Wall Street Zen

نشره MarketBeat · الولايات المتحدة منذ 14 د
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

ملخص مفصل

Wall Street Zen raised shares of Milestone Pharmaceuticals from a "strong sell" rating to a "sell" rating in a report on Saturday.

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

The Motley Fool

Prediction: 2 Stocks That Will Be Worth More Than SpaceX 5 Years From Now

 Seeking Alpha

ArrowMark Financial declares $0.15 dividend

 MarketWatch

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

 Stocktwits

Trump Reportedly Plans To Not Raise Nvidia Spy Issue During China Trip — Elon Musk To Accompany US President

 Yahoo Finance

Planning to Claim Social Security at 62? Here Are 3 Critical Questions to Ask Yourself First

 CNBC

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker